Neuronal optogenetics as a new topic of technology assessment?

Hans Zillmann

doi:10.14512/tatup.7225

Authors

Hans Zillmann Faculty of Philosophy, University of Erfurt, Erfurt (DE) https://orcid.org/0000-0003-2930-4131 hans.zillmann@uni-erfurt.de

DOI:

https://doi.org/10.14512/tatup.7225

Keywords:

neuronal optogenetics, technology assessment, genetic engineering

Abstract

This article is intended as a sketchy reflection on the question of the extent to which neuronal optogenetics could become a future topic of technology assessment (TA). To this end, we must first take a closer look at what technologies should be the subject of TA and what tasks can be ascribed to TA. In addition, an exemplary and also sketchy examination is made of whether TA on genetic engineering has already dealt with questions that arise in connection with genetic interventions in neuronal optogenetics. In this way, it can be determined whether neuronal optogenetics raises new questions for TA or requires new answers from it. The results suggest that a TA of neuronal optogenetics is needed.

References

Adamczyk, Agnieszka; Zawadzki, Przemyslaw (2020): The memory-modifying potential of optogenetics and the need for neuroethics. In: Nanoethics 14, pp. 207–225. https://doi.org/10.1007/s11569-020-00377-1

Albrecht, Steffen; König, Harald; Sauter, Arnold (2021): Genome Editing am Menschen. Endbericht zum Monitoring. TAB-Arbeitsbericht 191. Berlin: Büro für Technikfolgenabschätzung beim Deutschen Bundestag.

Bentley, Nicole; Chester, Cindy; Stacey, William; Patil, Parag (2013): Optogenetics in epilepsy. In: Neurosurgical Focus 34 (6). p. E4. https://doi.org/10.3171/2013.3.FOCUS1364

Böschen, Stefan; Grunwald, Armin; Krings, Bettina-Johanna; Rösch, Christine (2021): Technikfolgenabschätzung. Neue Zeiten, neue Aufgaben. In: Stefan Böschen, Armin Grunwald, Bettina-Johanna Krings and Christine Rösch (eds.): Technikfolgenabschätzung. Handbuch für Wissenschaft und Praxis. Baden-Baden: Nomos, pp. 15–40.

Bührlen, Bernhard; Vollmar, Horst (2009): Biomedizinische Innovationen und klinische Forschung. Wettbewerbs- und Regulierungsfragen. TAB-Arbeitsbericht 132. Berlin: Büro für Technikfolgenabschätzung beim Deutschen Bundestag.

Chen, Yuejun; Xiong, Man; Zhang, Su-Chun (2015): Illuminating parkinson’s therapy with optogenetics. In: Nature Biotechnology 33 (2), pp. 149–150. https://doi.org/10.1038/nbt.3140

Decker, Michael; Linder, Ralf; Lingner, Stephan; Scherz, Constanze; Sotoudeh, Mashid (2018): Grand Challenges meistern – der Beitrag der Technikfolgenabsschätzung. In: Michael Decker, Ralf Lindner, Stephan Lingner, Constanze Scherz and Mahshid Sotoudeh (eds.): ‚Grand Challenges‘ meistern. Der Beitrag der Technikfolgenabschätzung. Baden-Baden: Nomos, pp. 11–16.

Dederer, Hans-Georg; Hamburger, David (eds.) (2022): Brain organoids in research and therapy. Fundamental ethical and legal aspects. Cham: Springer.

Deubner, Jan; Coloun, Philippe; Diester, Ilka (2019): Optogenetic approaches to study the mammalian brain. In: Current Opinion in Structural Biology 57, pp. 157–163. https://doi.org/10.1016/j.sbi.2019.04.003

DiGuiseppi, Joseph; Zuo, Jian (2019): The awesome power of optogenetics in hearing research. In: Neuroscience Letters 701, pp. 175–179. https://doi.org/10.1016/j.neulet.2019.02.037

Ehrmann, Nadine; Pauls, Dennis (2020): Optogenetics. Illuminating neuronal circuits of memory formation. In: Journal of Neurogenetics 34 (1), pp. 47–54. https://doi.org/10.1080/01677063.2019.1708352

Etter, Guillaume et al. (2019): Optogenetic gamma stimulation rescues memory impairments in an Alzheimer’s disease mouse model. In: Nature Communication 10 (1), p. 5322. https://doi.org/10.1038/s41467-019-13260-9

Faltus, Timo; Freise, Johannes; Fluck, Carsten; Zillmann, Hans (2023): Ethics and regulation of neuronal optogenetics in the European Union. In: Pflügers Archiv 475, pp. 1505–1517. https://doi.org/10.1007/s00424-023-02888-8

Garciá-Delgado et al. (2022): Brain organoids to evaluate cellular therapies. In: Animals 12 (22), p. 3150. https://doi.org/10.3390/ani12223150

Gundelach, Lili; Hüser, Marc; Beutner, Dirk; Ruther, Patrick; Bruegmann, Tobias (2020): Towards the clinical translation of optogenetic skeletal muscle stimulation. In: Pflügers Archiv 472, pp. 527–545. https://doi.org/10.1007/s00424-020-02387-0

Hardt, Annika (2019): Technikfolgenabschätzung des CRISPR/Cas-Systems. Über die Anwendung in der menschlichen Keimbahn. Berlin: De Gruyter.

Kollek, Regina (2021): Lebenswissenschaften und Technikfolgenabschätzung. In: Stefan Böschen, Armin Grunwald, Bettina-Johanna Krings and Christine Rösch (eds.): Technikfolgenabschätzung. Handbuch für Wissenschaft und Praxis. Baden-Baden: Nomos, pp. 59–82.

Koralesky, Katherine; Sirovica, Lara; Hendricks, Jillian; Mills, Katelyn; Keyserlingk, Marina von; Weary, Daniel (2023): Social acceptance of genetic engineering technology. In: Public Library of Science 18 (8), p. e0290070. https://doi.org/10.1371/journal.pone.0290070

Lang, Alexander et al. (2019): Genome editing. Interdisziplinäre Technikfolgenabschätzung. Zürich: vdf. https://doi.org/10.3218/3982-5

Le Bras, Alexandra (2021): Off-target effects of optogenetics. In: Lab Animal 50 (11), p. 308. https://doi.org/10.1038/s41684-021-00883-z

Luo, Yi-Fan et al. (2023): Divergent projections of the prelimbic cortex mediate autism- and anxiety-like behaviors. In: Molecular Psychiatry 28 (6), pp. 2343–2354. https://doi.org/10.1038/s41380-023-01954-y

Mehnert, Wenzel; Grunwald, Armin (2024): Hermeneutic technology assessment. In: Armin Grunwald (ed.): Handbook of technology assessment. Cheltenham: Edward Elgar Publishing, pp. 281–290.

Mutter, Marion; Benkner, Boris; Münch, Thomas (2017): Optogenetik als mögliche Therapie bei degenerativen Netzhauterkrankungen. In: Medizinische Genetik 29 (2), pp. 239–247. https://doi.org/10.1007/s11825-017-0135-5

Neghab, Hoda et al. (2020): The state of the art of biomedical applications of optogenetics. In: Lasers in Surgery and Medicine 54 (2), pp. 202–216. https://doi.org/10.1002/lsm.23463

Nogrady, Bianca (2020): How cancer genomics is transforming diagnosis and treatment. In: Nature 579 (7800), pp. 10–11. https://doi.org/10.1038/d41586-020-00845-4

Obi-Nagata, Kisho; Temma, Yusuke; Hayashi-Takagi, Akiko (2019): Synaptic functions and their disruption in schizophrenia. From clinical evidence to synaptic optogenetics in an animal model. In: Proceedings of the Japan Academy 95 (5), pp. 179–197. https://doi.org/10.2183/pjab.95.014

Salmaninejad, Arash et al. (2021): Common therapeutic advances for Duchenne muscular dystrophy (DMD). In: International Journal of Neuroscience 131 (4), pp. 370–389. https://doi.org/10.1080/00207454.2020.1740218

Simonis, Georg (2013): Einführung. In: Georg Simonis (ed.): Konzepte und Verfahren der Technikfolgenabschätzung. Wiesbaden: Springer, pp. 11–19.

Stryjewska, Agnieszka; Kiepura, Katarzyna; Liborwski, Tadeusz; Lochyñski, Stanislaw (2013): Biotechnology and genetic engineering in the new drug development. DNA technology and recombinant proteins. In: Pharmacological Reports 65 (5), pp. 1072–1085. https://doi.org/10.1016/s1734-1140(13)71466-x

Swierstra, Tsjalling; Rip, Arie (2007): Nano-ethics as NEST-ethics. Patterns of moral argumentation about new and emerging science and technology. In: Nanoethics 1 (1), pp. 3–20. https://doi.org/10.1007/s11569-007-0005-8

Tovote, Phillip; Fadok, Jonathan; Lüthi, Andreas (2015): Neuronal circuits for fear and anxiety. In: Nature Reviews Neuroscience 16 (6), pp. 317–313. https://doi.org/10.1038/nrn3945

UMG – Universitätsmedizin Göttingen (2024): Else Kröner-Fresenius-Zentrum für optogenetische Therapien bewilligt. Presseinformation 044 / 2024, 08.03.2024. Available online at https://www.umg.eu/news-detail/news-detail/detail/news/else-kroener-fresenius-zentrum-fuer-optogenetische-therapien-bewilligt/, last accessed on 24.03.2025.

Vogt, Markus et al. (2021): Direct optogenetic stimulation of smooth muscle cells to control gastric contractility. In: Theranostics 11 (11), pp. 5569–5584. https://doi.org/10.7150/thno.53883

Wang, Yang; Zhang, Ziqi; Luo, Jingwen; Han, Xuejiao; Wei, Yuquan; Wei, Xiawei (2021): mRNA vaccine. A potential therapeutic strategy. In: Molecular Cancer 20 (1), pp. 33. https://doi.org/10.1186/s12943-021-01311-z

Zagha, Naime; Winner, Beate (2022): Development of brain organoids with genome-edited IPSC-derived brain cells. In: Hans-Georg Dederer and David Hamburger (eds.): Brain organoids in research and therapy. Fundamental ethical and legal aspects. Cham: Springer, pp. 21–34.

Zawadzki, Przemyslaw; Adamczyk, Agnieszka (2021): Personality and authenticity in light of the memory modifying potential of optogenetics. In: AJOB Neuroscience 12 (1), pp. 3–21. https://doi.org/10.1080/21507740.2020.1866097

Zweck, Axel (2013): Technikbewertung auf Basis ders VDI-Richtlinie 3780. In: Georg Simonis (ed.): Konzepte und Verfahren der Technikfolgenabschätzung. Wiesbaden: Springer, pp. 145–160.